financetom
Business
financetom
/
Business
/
Johnson & Johnson Completes Ambrx Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Johnson & Johnson Completes Ambrx Acquisition
Mar 7, 2024 9:06 AM

11:34 AM EST, 03/07/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Thursday it completed its acquisition of Ambrx Biopharma in an all-cash deal for an equity value of about $2 billion, or $1.9 billion net of estimated cash acquired.

The deal will be accounted for as a business combination, Johnson & Johnson ( JNJ ) said.

Price: 159.35, Change: +0.01, Percent Change: +0.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Regency Centers Insider Sold Shares Worth $1,808,000, According to a Recent SEC Filing
Regency Centers Insider Sold Shares Worth $1,808,000, According to a Recent SEC Filing
Feb 20, 2025
12:35 PM EST, 02/20/2025 (MT Newswires) -- Martin E Stein Jr, Director, Executive Chairman, on February 18, 2025, sold 25,000 shares in Regency Centers ( REG ) for $1,808,000. Following the Form 4 filing with the SEC, Stein has control over a total of 801,804 common shares of the company, with 287,958 shares held directly and 513,846 controlled indirectly. SEC...
--C&F Financial Raises Quarterly Dividend 5% to $0.46 Per Share; Payable April 1 to Shareholders of Record on March 14
--C&F Financial Raises Quarterly Dividend 5% to $0.46 Per Share; Payable April 1 to Shareholders of Record on March 14
Feb 20, 2025
12:35 PM EST, 02/20/2025 (MT Newswires) -- Price: 82.14, Change: -2.56, Percent Change: -3.02 ...
Gildan Activewear Target Lifted to $83, Outperform Rating Reiterated, at National Bank
Gildan Activewear Target Lifted to $83, Outperform Rating Reiterated, at National Bank
Feb 20, 2025
12:39 PM EST, 02/20/2025 (MT Newswires) -- National Bank has increased its one year target on Gildan Activewear ( GIL ) to $83 (from $78) and reiterated its Outperform rating, after the company reported fourth-quarter adjusted EPS of $0.83, beating National Bank's $0.80 estimate. Leadership changes were announced, which were anticipated. While quarterly results were functionally in line, our impression...
US FTC says it launches inquiry on tech censorship
US FTC says it launches inquiry on tech censorship
Feb 20, 2025
WASHINGTON, Feb 20 (Reuters) - The U.S. Federal Trade Commission launched a public inquiry on Thursday on how technology platforms deny or degrade users' access to services based on the content of their speech, it said in a statement. President Donald Trump last month signed an executive order that he said aims to restore freedom of speech and end censorship....
Copyright 2023-2026 - www.financetom.com All Rights Reserved